BEAM
Price
$17.29
Change
+$0.29 (+1.71%)
Updated
Apr 15, 04:59 PM (EDT)
Capitalization
1.7B
28 days until earnings call
PYXS
Price
$0.93
Change
+$0.01 (+1.09%)
Updated
Apr 15, 04:59 PM (EDT)
Capitalization
56.36M
24 days until earnings call
Ad is loading...

BEAM vs PYXS

Header iconBEAM vs PYXS Comparison
Open Charts BEAM vs PYXSBanner chart's image
Beam Therapeutics
Price$17.29
Change+$0.29 (+1.71%)
Volume$57.81K
Capitalization1.7B
Pyxis Oncology
Price$0.93
Change+$0.01 (+1.09%)
Volume$3.05K
Capitalization56.36M
BEAM vs PYXS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PYXS commentary
Apr 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PYXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 16, 2025
Stock price -- (BEAM: $17.00 vs. PYXS: $0.92)
Brand notoriety: BEAM and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 117% vs. PYXS: 66%
Market capitalization -- BEAM: $1.7B vs. PYXS: $56.36M
BEAM [@Biotechnology] is valued at $1.7B. PYXS’s [@Biotechnology] market capitalization is $56.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • PYXS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +11.11% price change this week, while PYXS (@Biotechnology) price change was -4.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.87%. For the same industry, the average monthly price growth was -13.42%, and the average quarterly price growth was -21.44%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

PYXS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+8.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.7B) has a higher market cap than PYXS($56.4M). BEAM YTD gains are higher at: -31.452 vs. PYXS (-41.346). PYXS has higher annual earnings (EBITDA): -65.51M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. PYXS (127M). PYXS has less debt than BEAM: PYXS (20.2M) vs BEAM (161M). BEAM has higher revenues than PYXS: BEAM (63.5M) vs PYXS (16.1M).
BEAMPYXSBEAM / PYXS
Capitalization1.7B56.4M3,009%
EBITDA-383.98M-65.51M586%
Gain YTD-31.452-41.34676%
P/E RatioN/AN/A-
Revenue63.5M16.1M394%
Total Cash851M127M670%
Total Debt161M20.2M797%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPYXS
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Bullish Trend 26 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL202.524.37
+2.21%
Apple
GME26.980.58
+2.20%
GameStop Corp
BTC.X84542.390000857.406250
+1.02%
Bitcoin cryptocurrency
SPY539.125.18
+0.97%
SPDR® S&P 500® ETF
TSLA252.350.04
+0.02%
Tesla

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+9.89%
CRSP - BEAM
72%
Closely correlated
-1.25%
RXRX - BEAM
64%
Loosely correlated
-4.34%
NTLA - BEAM
64%
Loosely correlated
+1.21%
DNLI - BEAM
58%
Loosely correlated
+4.49%
VERV - BEAM
57%
Loosely correlated
+26.38%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been closely correlated with KURA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-4.56%
KURA - PYXS
68%
Closely correlated
+1.39%
BLRX - PYXS
46%
Loosely correlated
+5.09%
ABOS - PYXS
43%
Loosely correlated
-0.90%
BEAM - PYXS
42%
Loosely correlated
+9.89%
RXRX - PYXS
41%
Loosely correlated
-4.34%
More